Medical/Healthcare News

Mitochon Pharmaceuticals Embarks on Groundbreaking Clinical Trial Targeting Four Neurodegenerative Diseases

BLUE BELL, PA — Mitochon Pharmaceuticals recenlty secured approval from the European Medicines Agency (EMA) to initiate a pioneering Phase I/IIa biomarker study, marking a significant milestone in the fight …

Mitochon Pharmaceuticals Embarks on Groundbreaking Clinical Trial Targeting Four Neurodegenerative Diseases Read More